NCT05310669View on ClinicalTrials.gov

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2030

Conditions
Fibrosis, Pulmonary
Interventions
DEVICE

Nasal pressure assessment

Once the patient is enrolled nasal pressure will be measured through a dedicated pressure line located at the nostril entrance and connected to a dedicated pressure transducer (OptiVentTM, SIDAM, Mirandola, Italy). Measured nasal pressure will be the result of the variation between inspiratory and expiratory pressure (DeltaPnose).

Trial Locations (1)

Unknown

RECRUITING

Azienda Ospedaliero Universitaria Policlinico di Modena, Modena

All Listed Sponsors
lead

University of Modena and Reggio Emilia

OTHER